Myocardial reperfusion with tirofiban injection via aspiration catheter

Zhang, Z; Li, W; Wu, Wayne; Xie, Qiang; Li, J; Zhang, W; Zhang, Y

doi:10.1007/s00059-018-4716-0

Cited by 10 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…After excluding duplicate research and screening the titles and abstracts of these potential articles, we reviewed 14 potentially relevant articles in full. After a comprehensive evaluation, 9 RCTs were involved in the analysis [ 15 , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] ] ( Fig. 1 ).…”

Section: Resultsmentioning

confidence: 99%

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Tian¹,

Liu²,

Zhang³

et al. 2023

Heliyon

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Tian¹,

Liu²,

Zhang³

et al. 2023

Heliyon

View full text Add to dashboard Cite

“…Также интересным было изучение селективного введения тирофибана в инфаркт-связанную коронарную артерию во время первичного ЧКВ [21]. Пациенты с ИМпST (n=122), которым выполнялось первичное ЧКВ, были разделены на 2 группы: внутривенное введение тирофибана (n=61) и интракоронарное его введение через аспирационный катетер в инфаркт-связанную артерию (n=61).…”

Section: чрескожное коронарное вмешательствоunclassified

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention

Терещенко

Меркулов

Samko

2020

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Recently, there has been a positive trend to reduce mortality from myocardial infarction. One of the reasons for such dynamics is the development of angiographic service in our country and the increase in the number of primary percutaneous coronary interventions. One of the most serious complications of endovascular interventions affecting the prognosis is the development of the phenomenon of slow or unrecoverable blood flow (≪slow/no-reflow≫ phenomenon). The reason for the development of this phenomenon is associated, first of all, with distal embolization by thrombotic masses and fragments of atherosclerotic plaque. In order to prevent this complication, manual thromboextraction was developed – the aspiration of thrombotic masses from the infarct-related artery. The manual thrombus aspiration has not been proven effective in a number of large randomized trials. In addition to the lack of influence on the prognosis, the method of manual thrombus aspiration significantly more often led to the development of ischemic strokes and currently should not be routinely carried out. Another method of preventing the phenomenon of delayed or unrecoverable blood flow is the use of glycoprotein IIb/IIIa receptor inhibitors which is, in contrast to the instrumental method, effective and relatively safe. According to a number of large randomized trials, drug treatment of this complication influences life expectancy in patients with ST-elevation myocardial infarction. At a time when there is already a meta-analysis on the routine use of glycoprotein IIb/IIIa receptor inhibitors during primary percutaneous coronary intervention and their positive impact on survival, in our country, unfortunately, the importance of these drugs is underestimated and according to the register they are used only in 3% of patients with ST-segment elevation myocardial infarction. This review presents studies and comparisons of glycoprotein IIb/IIIa receptor inhibitors existing on the market.

show abstract

Primary and Rescue PCI in STEMI

Fitzgerald¹,

Thiele²

2022

Interventional Cardiology

View full text Add to dashboard Cite

Myocardial reperfusion with tirofiban injection via aspiration catheter

Abstract: Selective tirofiban injection via TA catheter during PPCI may improve myocardial reperfusion in STEMI patients with large thrombus burden.

Cited by 10 publications

References 21 publications

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention

Primary and Rescue PCI in STEMI

Contact Info

Product

Resources

About